RPRX

Q: What is the price of Royalty Pharma (RPRX) today?

The current price of Royalty Pharma (RPRX) is $ 50.00, representing a 57.12% gain over the past year. The stock began the year trading around $ 38.64 and is currently priced at $ 50.00. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Royalty Pharma (RPRX) pay dividends?

In the last year, Royalty Pharma (RPRX) distributed dividends in the month of March, totaling $ 0.24. The Dividend Yield for the last 12 months is 1.79%.

Royalty Pharma PLC

Price

$ 50.00

return (12m)

57.12%

p/e

27.77

p/bv

2.20

DIVIDEND YIELD

1.79%

RPRX price

RPRX

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment RPRX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

10.23%

3 months

26.42%

1 year

57.12%

2 years

87.45%

5 years

31.53%

10 years

0.00%

Fundamentals RPRX

review the fundamentals of Royalty Pharma shares

P/E

27.77

Sector: -1,794.89 Industry: 13.93

P/S (PSR)

9.00

Sector: -3.19 Industry: 3.13

P/BV

2.20

Sector: -6.82 Industry: 0.97

DIVIDEND YIELD (DY)

1.79%

Sector: 0.39% Industry: 1.40%

ROA

3.93%

Sector: -1,450.91% Industry: 0.82%

ROE

7.93%

Sector: -3,200.15% Industry: 6.96%

ROIC

8.53%

Sector: -9.13% Industry: -

NET MARGIN

32.41%

Sector: -0.51% Industry: 24.25%

GROSS MARGIN

100.00%

Sector: -0.65% Industry: 5.49%

OPERATING MARGIN

65.54%

Sector: -5.90% Industry: 1.23%

EV/EBITDA

13.10

Sector: -3,830.39 Industry: 1.53

EV/EBIT

13.11

Sector: -3,757.01 Industry: 2.38

PRICE-TO-ASSETS

1.09

Sector: 0.13 Industry: 0.12

BVPS

22.70

Sector: -1,464.96 Industry: 22.77

EPS

1.80

Sector: -6,115.74 Industry: 1.59

EQUITY-TO-ASSETS RATIO

0.50

Sector: -0.01 Industry: 0.12

LIABILITIES / ASSETS

0.50

Sector: 0.30 Industry: 0.79

CAGR REVENUE 5 YEARS

0.76%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

4.46%

Sector: - Industry: -

FAIR VALUE OF Royalty Pharma ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 50.00

Fair Value

$ 0.00

Upside/Downside Return potential.

-39.36%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals RPRX

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
JPM	14.24	2.30	16.18%	1.88%	$ 838.46 B	31.50%
NU	25.93	6.57	25.34%	0.00%	$ 74.38 B	27.00%
MA	31.24	60.37	193.24%	0.60%	$ 467.61 B	45.65%
BAC	12.29	1.30	10.58%	2.04%	$ 391.17 B	28.11%
BRK-B	15.29	1.42	9.30%	0.00%	$ 1.02 T	16.31%
HSBC	12.90	1.40	10.84%	4.00%	$ 287.48 B	33.65%
BRK-A	10.63	0.99	9.30%	0.00%	$ 712.08 B	16.31%
C	14.33	1.08	7.54%	1.79%	$ 229.60 B	18.16%
RY	16.45	2.46	14.94%	2.43%	$ 249.64 B	31.04%
BLK	26.07	0.00	0.00%	2.03%	$ 163.08 B	24.40%
PYPL	9.05	2.34	25.83%	0.55%	$ 47.35 B	15.78%
ING	11.60	1.41	12.16%	4.75%	$ 84.13 B	27.55%
PAGS	8.46	1.21	14.29%	4.44%	$ 3.24 B	12.72%
AXP	21.03	6.81	32.36%	0.99%	$ 227.87 B	15.00%
WFC	11.56	1.39	12.03%	2.15%	$ 250.74 B	25.53%
BBVA	11.58	1.92	16.62%	3.54%	$ 139.29 B	27.47%
XP	10.58	2.29	21.68%	0.95%	$ 9.90 B	64.74%
LYG	13.50	1.31	9.68%	2.98%	$ 83.71 B	23.92%
MS	16.27	0.00	0.00%	2.08%	$ 294.75 B	26.34%
BCS	8.82	0.81	9.13%	1.89%	$ 84.34 B	24.59%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

RPRX Historical Dividends

current DY: 1.79%

5-year average DY: 2.45%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	02/20/2026	03/10/2026	0,23500000
Dividends	11/14/2025	12/10/2025	0,22000000
Dividends	08/15/2025	09/10/2025	0,22000000
Dividends	05/16/2025	06/10/2025	0,22000000
Dividends	02/21/2025	03/10/2025	0,22000000
Dividends	11/15/2024	12/10/2024	0,21000000
Dividends	08/16/2024	09/13/2024	0,21000000
Dividends	05/17/2024	06/14/2024	0,21000000
Dividends	02/16/2024	03/15/2024	0,21000000
Dividends	11/17/2023	12/15/2023	0,20000000
Dividends	08/18/2023	09/15/2023	0,20000000
Dividends	05/19/2023	06/15/2023	0,20000000
Dividends	02/16/2023	03/15/2023	0,20000000
Dividends	11/18/2022	12/15/2022	0,19000000
Dividends	08/19/2022	09/15/2022	0,19000000
Dividends	05/20/2022	06/15/2022	0,19000000
Dividends	02/18/2022	03/15/2022	0,19000000
Dividends	11/19/2021	12/15/2021	0,17000000
Dividends	08/20/2021	09/15/2021	0,17000000
Dividends	05/20/2021	06/15/2021	0,17000000
Dividends	02/19/2021	03/15/2021	0,17000000
Dividends	11/20/2020	12/15/2020	0,15000000
Dividends	09/15/2020	09/30/2020	0,15000000

ABOUT Royalty Pharma

Royalty Pharma PLC

Average Investor10 user rating

4.0 (2 people)

United States

6 years

Founded: 2020

2020

Time since IPO - 6 years

-

Employees

Royalty Pharma PLC (United States) is listed on the Nasdaq and has a market capitalization of $21.40 Billions, with shareholders equity totaling $9.71 Billions.

The Company is listed on the [MARKET_NAME]

Over the past 12 months, Royalty Pharma PLC reported $2.38 Billions in revenue, generating net income of $770.74 Millions.

Key financial metrics include a P/E ratio of 27.77, a price-to-book (P/B) ratio of 2.20, and a trailing twelve-month dividend yield of 1.79%.

The company trades under the ticker RPRX.

Market cap

$ 21.40 Billions

Net worth

$ 9.71 Billions

$ 9,714,940,000.00

Assets

$ 19.62 Billions

$ 19,620,780,000.00

Total Shares Outstanding

428.00 Millions

428,000,000

Average Daily Trading Volume

$ 3.39 Millions

$ 3,390,317.74

Sector

Financial

Industry

Auxiliary Activities of Financial Services

RPRX

revenue by Business Segment Royalty Pharma

Revenue by Region Royalty Pharma

RPRX revenue and profits

Financial Results RPRX

DRAG THE FRAME TO SEE MORE DATA

RPRX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

BRK-A - Berkshire Hathaway

$ 712,077.81 --8,57% (12M)

P/E

10.63

0.00%

ROE

9.30%

P/BV

0.99

BRK-B - Berkshire Hathaway

$ 474.58 --8,42% (12M)

P/E

15.29

0.00%

ROE

9.30%

P/BV

1.42

JPM - JPMorgan

$ 310.29 37,21% (12M)

P/E

14.24

1.88%

ROE

16.18%

P/BV

2.30

SNEX - StoneX Group

$ 106.03 98,09% (12M)

P/E

15.03

0.00%

ROE

14.27%

P/BV

2.14

BAC - Bank of America

$ 53.91 47,35% (12M)

P/E

12.29

2.04%

ROE

10.58%

P/BV

1.30

C - Citigroup

$ 132.18 117,38% (12M)

P/E

14.33

1.79%

ROE

7.54%

P/BV

1.08

MET - MetLife

$ 78.08 10,83% (12M)

P/E

15.20

2.91%

ROE

11.68%

P/BV

1.78

AEG - Aegon

$ 8.11 45,01% (12M)

P/E

5.71

5.95%

ROE

21.11%

P/BV

1.21